Pfizer C440 (Solid Tumors)
What is the Purpose of this Study?
-Receive injections or infusions of the study drug, once every 2 weeks
-Have a tumor biopsy or provide old tumor tissue
-Provide blood samples
-Have physical exams, blood and urine tests
-Have imaging scans (CT and/or MRI)
-Have heart tests (ECG)
Who Can Participate in this Study?
Adults with solid tumors, including:
-Non-small cell lung carcinoma (NSCLC)
-Squamous cell carcinoma of the head and neck (SCCHN)
-Other types of cancer that the study doctor believes may be treated with this drug.
What is Involved?
We are doing this study to find out if the study drug is safe and to determine the most effective dose of the study drug.
the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PF-07257876 in patients with Advanced or Metastatic Tumors